Galápagos NV Maximizes AlphaSense to Significantly Expedite Actionable Insights

Galápagos NV, a biotech focused on oncology and immunology, faced fragmented, time-consuming competitive-intelligence gathering that required manually cross-checking multiple sources. After implementing AlphaSense, the team achieved a stated 120x acceleration in accessing earnings summaries and used Generative Search to quickly synthesize analyst views on market trends. The platform became a cross-functional "one-stop-shop" for CI discovery used by finance, business development, and clinical teams, with leadership saying they would "really struggle to do without" it.

AlphaSense is an AI-powered search platform over premium business documents, earnings calls, filings and expert-network transcripts, used by pharma competitive-intelligence and business-development teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.